AbbVie’s (ABBV) plan to close the $63 billion Allergan (AGN) deal this month appears on track following the announcement that they have received …
Investment banker Barclays announced it has initiated coverage of 20 U.S.
Mizuho analyst Irina Rivkind Koffler chimes in on Allergan plc Ordinary Shares (NYSE:AGN) on back of key competitor Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) announcing positive top-line Phase III …
Mizuho analyst Irina Rivkind Koffler is joining the earnings conversation with a preview for Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Allergan plc Ordinary Shares (NYSE:AGN) as …
Amid big changes underway for Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and an acquisition that has some investors raising an eyebrow at Allergan plc Ordinary Shares …
Allergan plc Ordinary Shares (NYSE:AGN) announced today that it had entered an agreement to acquire Vitae Pharmaceuticals Inc (NASDAQ:VTAE), a clinical-stage biotech company, …
Vitae Pharmaceuticals Inc (NASDAQ:VTAE) and Allergan plc (NYSE:AGN) announced that they have entered into a definitive agreement under which Allergan will acquire Vitae for $21.00 …
Credit Suisse analyst, Vamil Divan, initiates coverage on Allergen plc Ordinary Shares (NYSE:AGN) with an Outperform rating and a price target of $327.00.
It’s an eventful week ahead for pharmaceutical companies MannKind Corporation (NASDAQ:MNKD), Allergan plc Ordinary Shares (NYSE:AGN), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), and Horizon Pharma PLC …
Healthcare analysts explain why they are bullish on Allergan plc Ordinary Shares (NYSE:AGN) and Zafgen Inc (NASDAQ:ZFGN). Although many investors are worried that …